Picture of Carna Biosciences logo

4572 — Carna Biosciences News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Table: Garna Biosciences - 6-MTH group results

    Aug 6 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Jun 30, 2026        Jun 30, 2025       Dec 31, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            401 mln             251 mln           720 mln     
                 (+59.8 pct)         (-20.4 pct)       (+24.4 pct)   
  Operating     loss 954 mln          loss 1.05         loss 2.03    
  Recurring       loss 1.01           loss 1.06         loss 2.05    
  Net             loss 1.04           loss 1.06         loss 2.09    
  EPS          loss 53.13 yen      loss 55.29 yen    loss 108.95 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T 
     
 
 

Recent news on Carna Biosciences

See all news